Industry & Business

Synexa Life Sciences opens international HQ in Dublin

 Breaking News
  • Largest Ever European Investment Bank Support in Ireland The European Investment Bank is to provide a loan of €490 million to support construction of the new children’s hospital in Dublin. This represents the largest ever financial engagement by the European Union’s long-term lending institution in Ireland and the EIB’s first backing for a hospital in the country. The new children’s hospital project includes two [...]...
  • Strabane Manufacturer to Invest Over £7 Million in Ambitious Expansion Strabane-based Fabplus is planning to more than double its workforce and turnover with support from Invest Northern Ireland. The investment is part of a three year expansion plan to increase its market share in the Republic of Ireland and Great Britain, and gain a foothold in mainland Europe and Scandinavia. Recruitment is underway to employ 83 additional staff at [...]...
  • PM Group Appoints a New Non-Executive Director Michael McNicholas has been appointed as a Non-Executive Director of Project Management Holdings (PM Group), the Irish headquartered international project delivery specialists. Michael McNicholas. Michael has over 35 years’ experience in senior leadership positions in the public and private sectors. He is the former CEO of Ervia, NTR plc and Managing Director of ESB International.  During his [...]...
  • Center Parcs Signs Contract With John Sisk & Son As construction activity on the much anticipated €233 million Center Parcs Longford Forest resort in County Longford ramps up, the company has announced it has formally awarded two major construction contracts to Dublin-based construction firm John Sisk & Son. The contracts for the construction of the 470 lodges and 30 apartments as well as the state-of-the-art centre [...]...
  • Medi-Shower Invests in Innovation to Drive Export Growth Multi-award-winning manufacturer Medi-Shower has created ‘smart showerhead’ technology which can reduce the risk of Legionnaires disease. The cutting edge product, developed with R&D support from Invest Northern Ireland is designed to meet the high requirements for hygiene within the healthcare sector. It reduces the risk of waterborne infection from bacteria that can build up due to poor design [...]...

Synexa Life Sciences opens international HQ in Dublin

Synexa Life Sciences opens international HQ in Dublin
August 01
09:00 2017

Synexa Life Sciences, a global leader in biomarker services, has announced the opening of its international headquarters in Dublin. The new centre will be home to Synexa’s global business development activities and a new Bioinformatics Lab, and is expected to create up to 30 highly skilled jobs over the next five years.

Welcoming the decision by Synexa to open their international headquarters in Dublin, the Tánaiste and Minister for Enterprise and Innovation, Frances Fitzgerald said: “This is a great win for Ireland, bringing high quality jobs involving cutting-edge science and research for the biotechnology and pharmaceutical industry and will help drive the development of new products by the industry. The presence of Synexa here will bring considerable weight to our growing cluster of companies in a niche area of the life sciences sector and build on our existing expertise. I am confident that the company will be able to source the talent necessary, as a result of the Government’s commitment to pursuing skills availability for our high technology industries”.

Synexa operates biomarker research laboratories in Berlin, London and Cape Town, where the company was founded in 2003 by Irishman Paul O’Riordan (CEO) and two local scientists, Dr. Justin Devine and Prof. Patrick Bouic.  Mr O’Riordan qualified as an Irish chartered accountant in 1989, is a member of the Global Irish Network and sees Ireland as the perfect base from which to manage the company’s continued rapid growth.

“Ireland has a well-deserved reputation as one of the world’s most open and business-friendly environments, making the decision to locate our international HQ here very straightforward. The IDA has been extremely welcoming and professional, and Dublin’s rapidly growing ecosystem of high-tech companies, innovative research institutions and skilled young people makes it a very attractive place to build a business like ours,” he said.

Synexa’s new facility will include the creation of a Bioinformatics Lab, in which specialised data analysts and machine learning systems will interrogate the data generated in the company’s biomarker labs. Mr. O’Riordan believes “that that the richness of insight available about a drug’s performance and the ability to identify biomarker-based ‘signatures’ of response and non-response among patients will mean that bioinformatics analysis will become an essential tool for improving the efficiency of new drug development over the next decade.”

Synexa provides biomarker services to the global biotech and pharmaceutical industry. Biomarker analysis helps drug researchers to determine and predict a new drug’s safety and efficacy profile, identify likely patient responders and non-responders, and better understand how the drug works.  The global biomarker services industry has been growing very rapidly since 2010, as biopharma companies invest heavily in ‘precision medicine’ solutions – a future in which medical treatment and therapies are tailored to individual patients based on their predicted response or risk of disease.

Commenting on the announcement, Martin Shanahan, CEO of IDA Ireland said: “The decision by Synexa, to locate its International Headquarters in Dublin, marks an important win for Ireland in further developing the pharmaceutical biotechnology sector. The Synexa headquarters will be a welcome addition to the ever expanding life sciences cluster in Ireland and I look forward to working with the company as it continues to grow”.

About Author

editor

editor

Related Articles






New Subscriber





Subscribe Here



Advertisements
































National Manufacturing Conference & Exhibition 2016

NIBRT Springboard Success Stories



Upcoming Events

  • No upcoming events
AEC v1.0.4